Format
Sort by
Items per page

Send to

Choose Destination

Best matches for CB1 receptor:

Search results

Items: 1 to 20 of 8263

1.

Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer.

Tomko A, O'Leary L, Trask H, Achenbach JC, Hall SR, Goralski KB, Ellis LD, Dupré DJ.

Front Pharmacol. 2019 Sep 27;10:1124. doi: 10.3389/fphar.2019.01124. eCollection 2019.

PMID:
31611800
2.

Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.

Bilel S, Tirri M, Arfè R, Ossato A, Trapella C, Serpelloni G, Neri M, Fattore L, Marti M.

Neurotoxicology. 2019 Oct 11. pii: S0161-813X(19)30109-3. doi: 10.1016/j.neuro.2019.10.002. [Epub ahead of print]

PMID:
31610187
3.

D2 autoreceptor switches CB2 receptor effects on [3 H]-dopamine release in the striatum.

López-Ramírez G, Sánchez-Zavaleta R, Ávalos-Fuentes A, Sierra JJ, Paz-Bermúdez F, Leyva-Gómez G, Segovia Vila J, Cortés H, Florán B.

Synapse. 2019 Oct 14:e22139. doi: 10.1002/syn.22139. [Epub ahead of print]

PMID:
31610050
4.
5.

Cellular Distribution of Canonical and Putative Cannabinoid Receptors in Canine Cervical Dorsal Root Ganglia.

Chiocchetti R, Galiazzo G, Tagliavia C, Stanzani A, Giancola F, Menchetti M, Militerno G, Bernardini C, Forni M, Mandrioli L.

Front Vet Sci. 2019 Sep 19;6:313. doi: 10.3389/fvets.2019.00313. eCollection 2019.

PMID:
31608295
6.

CB1 and LPA1 Receptors Relationship in the Mouse Central Nervous System.

González de San Román E, Manuel I, Ledent C, Chun J, Rodríguez de Fonseca F, Estivill-Torrús G, Santín LJ, Rodríguez Puertas R.

Front Mol Neurosci. 2019 Sep 19;12:223. doi: 10.3389/fnmol.2019.00223. eCollection 2019.

PMID:
31607860
7.

CB1 enhanced the osteo/dentinogenic differentiation ability of periodontal ligament stem cells via p38 MAPK and JNK in an inflammatory environment.

Yan W, Cao Y, Yang H, Han N, Zhu X, Fan Z, Du J, Zhang F.

Cell Prolif. 2019 Oct 10:e12691. doi: 10.1111/cpr.12691. [Epub ahead of print]

PMID:
31599069
8.

Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.

Nguyen T, Gamage T, Decker AM, Barrus D, Langston TL, Li JX, Thomas BF, Zhang Y.

J Med Chem. 2019 Oct 9. doi: 10.1021/acs.jmedchem.9b01161. [Epub ahead of print]

PMID:
31596583
9.

Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

Milligan AL, Szabo-Pardi TA, Burton MD.

J Dual Diagn. 2019 Oct 9:1-14. doi: 10.1080/15504263.2019.1668100. [Epub ahead of print]

PMID:
31596190
10.

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor.

Alapafuja SO, Nikas SP, Ho TC, Tong F, Benchama O, Makriyannis A.

Molecules. 2019 Oct 1;24(19). pii: E3559. doi: 10.3390/molecules24193559.

11.

Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.

Kale VP, Gibbs S, Taylor JA, Zmarowski A, Novak J, Patton K, Sparrow B, Gorospe J, Anand S, Cinar R, Kunos G, Chorvat RJ, Terse PS.

Regul Toxicol Pharmacol. 2019 Sep 30;109:104483. doi: 10.1016/j.yrtph.2019.104483. [Epub ahead of print]

PMID:
31580887
12.

Brodifacoum does not modulate human cannabinoid receptor-mediated hyperpolarization of AtT20 cells or inhibition of adenylyl cyclase in HEK 293 cells.

Sachdev S, Boyd R, Grimsey NL, Santiago M, Connor M.

PeerJ. 2019 Sep 25;7:e7733. doi: 10.7717/peerj.7733. eCollection 2019.

13.

Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2.

Irungbam K, Churin Y, Matono T, Weglage J, Ocker M, Glebe D, Hardt M, Koeppel A, Roderfeld M, Roeb E.

Lab Invest. 2019 Sep 30. doi: 10.1038/s41374-019-0327-5. [Epub ahead of print]

PMID:
31570772
14.

Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice.

Peñasco S, Rico-Barrio I, Puente N, Fontaine CJ, Ramos A, Reguero L, Gerrikagoitia I, de Fonseca FR, Suarez J, Barrondo S, Aretxabala X, Del Caño GG, Sallés J, Elezgarai I, Nahirney PC, Christie BR, Grandes P.

Neuropsychopharmacology. 2019 Sep 30. doi: 10.1038/s41386-019-0530-5. [Epub ahead of print]

PMID:
31569197
15.

Photorelease of 2-Arachidonoylglycerol in Live Cells.

Laguerre A, Hauke S, Qiu J, Kelly MJ, Schultz C.

J Am Chem Soc. 2019 Oct 10. doi: 10.1021/jacs.9b05978. [Epub ahead of print]

PMID:
31560527
16.

Extractions of Medical Cannabis Cultivars and the Role of Decarboxylation in Optimal Receptor Responses.

Lewis-Bakker MM, Yang Y, Vyawahare R, Kotra LP.

Cannabis Cannabinoid Res. 2019 Sep 23;4(3):183-194. doi: 10.1089/can.2018.0067. eCollection 2019.

17.

Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors.

Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M.

Cannabis Cannabinoid Res. 2019 Sep 23;4(3):165-176. doi: 10.1089/can.2019.0016. eCollection 2019.

18.

Nabilone for the Treatment of Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness and Guidelines [Internet].

Cowling T, MacDougall D.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 20.

19.

Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Galaj E, Xi ZX.

CNS Drugs. 2019 Sep 23. doi: 10.1007/s40263-019-00664-w. [Epub ahead of print]

PMID:
31549358
20.

Characterisation and localisation of the endocannabinoid system components in the adult human testis.

Nielsen JE, Rolland AD, Rajpert-De Meyts E, Janfelt C, Jørgensen A, Winge SB, Kristensen DM, Juul A, Chalmel F, Jégou B, Skakkebaek NE.

Sci Rep. 2019 Sep 19;9(1):12866. doi: 10.1038/s41598-019-49177-y.

Supplemental Content

Loading ...
Support Center